Annual CFO:
-$109.03M-$17.08M(-18.58%)Summary
- As of today, EWTX annual cash from operations is -$109.03 million, with the most recent change of -$17.08 million (-18.58%) on December 31, 2024.
- During the last 3 years, EWTX annual cash from operations has fallen by -$75.52 million (-225.39%).
- EWTX annual cash from operations is now -1088.83% below its all-time high of -$9.17 million, reached on December 31, 2019.
Performance
EWTX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$34.78M-$2.19M(-6.73%)Summary
- As of today, EWTX quarterly cash from operations is -$34.78 million, with the most recent change of -$2.19 million (-6.73%) on September 30, 2025.
- Over the past year, EWTX quarterly cash from operations has dropped by -$7.40 million (-27.04%).
- EWTX quarterly cash from operations is now -1169.66% below its all-time high of -$2.74 million, reached on March 31, 2020.
Performance
EWTX Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$132.18M-$7.40M(-5.93%)Summary
- As of today, EWTX TTM cash from operations is -$132.18 million, with the most recent change of -$7.40 million (-5.93%) on September 30, 2025.
- Over the past year, EWTX TTM cash from operations has dropped by -$23.28 million (-21.38%).
- EWTX TTM cash from operations is now -4725.89% below its all-time high of -$2.74 million, reached on March 31, 2020.
Performance
EWTX TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
EWTX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -18.6% | -27.0% | -21.4% |
| 3Y3 Years | -225.4% | -189.8% | -163.1% |
| 5Y5 Years | -1088.8% | - | - |
EWTX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -225.4% | at low | -194.2% | +8.2% | -163.1% | at low |
| 5Y | 5-Year | -1088.8% | at low | -772.7% | +8.2% | -1865.8% | at low |
| All-Time | All-Time | -1088.8% | at low | -1169.7% | +8.2% | -4725.9% | at low |
EWTX Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$34.78M(-6.7%) | -$132.18M(-5.9%) |
| Jun 2025 | - | -$32.58M(+14.0%) | -$124.78M(-5.5%) |
| Mar 2025 | - | -$37.87M(-40.5%) | -$118.30M(-8.5%) |
| Dec 2024 | -$109.03M(-18.6%) | -$26.96M(+1.5%) | -$109.03M(-0.1%) |
| Sep 2024 | - | -$27.37M(-4.9%) | -$108.90M(-5.1%) |
| Jun 2024 | - | -$26.10M(+8.7%) | -$103.58M(-6.0%) |
| Mar 2024 | - | -$28.60M(-6.6%) | -$97.72M(-6.3%) |
| Dec 2023 | -$91.95M(-74.7%) | -$26.83M(-21.6%) | -$91.95M(-19.5%) |
| Sep 2023 | - | -$22.06M(-9.0%) | -$76.94M(-15.0%) |
| Jun 2023 | - | -$20.23M(+11.4%) | -$66.88M(-6.3%) |
| Mar 2023 | - | -$22.83M(-93.1%) | -$62.89M(-19.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$52.63M(-57.1%) | -$11.82M(+1.5%) | -$52.63M(-4.8%) |
| Sep 2022 | - | -$12.00M(+26.1%) | -$50.23M(-8.0%) |
| Jun 2022 | - | -$16.25M(-29.2%) | -$46.50M(-16.2%) |
| Mar 2022 | - | -$12.57M(-33.5%) | -$40.02M(-19.4%) |
| Dec 2021 | -$33.51M(-129.0%) | -$9.42M(-14.0%) | -$33.51M(-39.1%) |
| Sep 2021 | - | -$8.26M(+15.4%) | -$24.09M(-52.2%) |
| Jun 2021 | - | -$9.77M(-61.3%) | -$15.83M(-57.6%) |
| Mar 2021 | - | -$6.06M(-52.0%) | -$10.04M(-49.3%) |
| Dec 2020 | -$14.63M(-59.6%) | - | - |
| Jun 2020 | - | -$3.98M(-45.5%) | -$6.72M(-145.5%) |
| Mar 2020 | - | -$2.74M | -$2.74M |
| Dec 2019 | -$9.17M | - | - |
FAQ
- What is Edgewise Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Edgewise Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Edgewise Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Edgewise Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of EWTX is -$109.03M
What is the all-time high annual cash from operations for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high annual cash from operations is -$9.17M
What is Edgewise Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, EWTX annual cash from operations has changed by -$17.08M (-18.58%)
What is Edgewise Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of EWTX is -$34.78M
What is the all-time high quarterly cash from operations for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high quarterly cash from operations is -$2.74M
What is Edgewise Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, EWTX quarterly cash from operations has changed by -$7.40M (-27.04%)
What is Edgewise Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of EWTX is -$132.18M
What is the all-time high TTM cash from operations for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high TTM cash from operations is -$2.74M
What is Edgewise Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, EWTX TTM cash from operations has changed by -$23.28M (-21.38%)